Treatment of 5 dogs with immune-mediated thrombocytopenia using Romiplostim

BACKGROUND: Immune thrombocytopenia (ITP) in dogs is analogous to that in humans. Romiplostim, a novel thrombopoietin receptor (TPO-R) agonist, is currently used for the treatment of refractory ITP in humans, but not in dogs. Here, we describe the response to romiplostim in five dogs with refractory...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohn, Barbara, Bal, Gürkan, Chirek, Aleksandra, Rehbein, Sina, Salama, Abdulgabar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901510/
https://www.ncbi.nlm.nih.gov/pubmed/27283401
http://dx.doi.org/10.1186/s12917-016-0718-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901510/
https://www.ncbi.nlm.nih.gov/pubmed/27283401
http://dx.doi.org/10.1186/s12917-016-0718-4

Ejemplares similares